PepsiCo's Snack Business Under Scrutiny as Cramer Flags GLP-1 Drug Impact
CNBC's Jim Cramer has placed PepsiCo on his radar, expressing specific concerns that the consumer giant's Frito-Lay snack division faces headwinds from the rising popularity of GLP-1 weight-loss drugs, even as the stock shows recent strength.